These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9267705)

  • 21. C-terminal domain of apolipoprotein CII as both activator and competitive inhibitor of lipoprotein lipase.
    Cheng Q; Blackett P; Jackson KW; McConathy WJ; Wang CS
    Biochem J; 1990 Jul; 269(2):403-7. PubMed ID: 2386483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bovine milk lipoprotein lipase transfers tocopherol to human fibroblasts during triglyceride hydrolysis in vitro.
    Traber MG; Olivecrona T; Kayden HJ
    J Clin Invest; 1985 May; 75(5):1729-34. PubMed ID: 3998153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of apolipoprotein C-II on the lipoprotein lipase-catalyzed hydrolysis of dihexanoyl- and diheptanoyl-phosphatidylcholine.
    Shinomiya M; Jackson RL
    Biochem Biophys Res Commun; 1983 Jun; 113(3):811-6. PubMed ID: 6870893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of lipid transfer proteins on lipoprotein lipase induced transformation of VLDL and HDL.
    Murdoch SJ; Breckenridge WC
    Biochim Biophys Acta; 1996 Oct; 1303(3):222-32. PubMed ID: 8908157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VLDL substrate properties and efficiency of their metabolic transformation by LPL.
    Dergunov AD; Shuvaev VV; Perova NV
    Experientia; 1989 May; 45(5):461-3. PubMed ID: 2721636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoprotein lipase-catalyzed hydrolysis of tri[14C]oleoylglycerol in a phospholipid interface. A monolayer study.
    Demel RA; Shirai K; Jackson RL
    Biochim Biophys Acta; 1982 Dec; 713(3):629-37. PubMed ID: 7150631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of purified bovine milk lipoprotein lipase by propranolol and other beta-adrenergic blockers in vitro.
    Kubo M; Hostetler KY
    Biochim Biophys Acta; 1987 Apr; 918(2):168-74. PubMed ID: 2881580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and properties of immobilized lipoprotein lipase.
    Matsuoka N; Shirai K; Jackson RL
    Biochim Biophys Acta; 1980 Nov; 620(2):308-16. PubMed ID: 7437456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of the phospholipase A1 activity of lipoprotein lipase by apoprotein C-II.
    Stocks J; Galton DJ
    Lipids; 1980 Mar; 15(3):186-90. PubMed ID: 7374370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of human and bovine milk lipoprotein lipase and the mechanism of enzyme activation by apolipoprotein C-II.
    Posner I; Wang CS; McConathy WJ
    Comp Biochem Physiol B; 1985; 80(1):171-4. PubMed ID: 3967487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Kinetics of triolein hydrolysis by lipoprotein lipase in the presence of apoprotein C-II].
    Dergunov AD; Shuvaev VV; Sokol'nikov AA; Metel'skaia VA; Perova NV
    Dokl Akad Nauk SSSR; 1985; 281(1):195-200. PubMed ID: 3996199
    [No Abstract]   [Full Text] [Related]  

  • 32. Characterization of lipoprotein lipase activators from equine plasma.
    Le Goff D; Hannan J; Maboundou JC; Ayrault-Jarrier M
    Biochem Int; 1992 Dec; 28(5):795-804. PubMed ID: 1288492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological studies on bovine milk lipoprotein lipase. Effects of Fab fragments on enzyme activity.
    Shirai K; Wisner DA; Johnson JD; Srivastava LS; Jackson RL
    Biochim Biophys Acta; 1982 Jul; 712(1):10-20. PubMed ID: 6180771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of albumin and apolipoprotein C-II on the acyl-chain specificity of lipoprotein lipase catalysis.
    Wang CS; Bass H; Whitmer R; McConathy WJ
    J Lipid Res; 1993 Dec; 34(12):2091-8. PubMed ID: 8301229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans.
    Stalenhoef AF; Malloy MJ; Kane JP; Havel RJ
    Proc Natl Acad Sci U S A; 1984 Mar; 81(6):1839-43. PubMed ID: 6584917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and characterization of lipoprotein lipase activators from bovine blood serum.
    Sundheim G; Zimmer TL; Astrup HN
    J Dairy Sci; 1983 Mar; 66(3):407-14. PubMed ID: 6841745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein C-II deficiency. The role of apolipoprotein C-II in the hydrolysis of triacylglycerol-rich lipoproteins.
    Haberbosch W; Poli A; Baggio G; Fellin R; Gnasso A; Augustin J
    Biochim Biophys Acta; 1984 Mar; 793(1):49-60. PubMed ID: 6704413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid binding of apolipoprotein CII is required for stimulation of lipoprotein lipase activity against apolipoprotein CII-deficient chylomicrons.
    Olivecrona G; Beisiegel U
    Arterioscler Thromb Vasc Biol; 1997 Aug; 17(8):1545-9. PubMed ID: 9301634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein lipase: mechanism of action and role in lipoprotein metabolism.
    Quinn D; Shirai K; Jackson RL
    Prog Lipid Res; 1983; 22(1):35-78. PubMed ID: 6346343
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.